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arothu_vamsi@re
responsibility of XAbstract An isocratic stability indicating RP-HPLC–UV method is presented for the determina-
tion of metaxalone (MET) in the presence of its degradation products. The method uses Dr. Maisch
C18 column (250 mm 4.6 mm, 5 mm) with mobile phase consisting of acetonitrile–potassium
dihydrogen orthophosphate buffer with 4 mL of 0.4% triethyl amine (pH 3.0; 10 mM) (58:42, v/v)
at a ﬂow rate of 1.0 mL/min. pH of the buffer was adjusted with o-phosphoric acid. UV detection
was performed at 225 nm. The method was validated for speciﬁcity, linearity, precision, accuracy,
limit of detection, limit of quantiﬁcation and robustness. The calibration plot was linear over the
concentration range of 1–100 mg/mL having a correlation coefﬁcient (r2) of 0.999. Limits of
detection and quantiﬁcation were 0.3 and 1 mg/mL, respectively. Intra-day and inter-day precision
(% RSD) was 0.65 and 0.79 respectively. The proposed method was used to investigate the
degradation kinetics of MET under different stress conditions employed. Degradation of MET
followed a pseudo-ﬁrst-order kinetics, and rate constant (K), time left for 50% potency (t1/2), and
time left for 90% potency (t90) were calculated.
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i’an Jiaotong University.1. Introduction
Metaxalone (MET) is a muscle relaxant used to relax muscles
and relieve pain caused by strains, sprains, and other muscu-
loskeletal conditions. Chemically, it is 5-[3, 5-dimethylphenoxy
methyl]-2-oxazolidinone (Fig. 1) [1]. The ﬁrst published report
about the use of MET as a skeletal muscle relaxant appeared
in the1960s [2]. The mechanism of action of MET in humans
has not been established, but may be due to general centrallsevier B.V. All rights reserved.
OOO
NH
Figure 1 Chemical structure of MET.
V.K. Marothu et al.432nervous system depression. MET has no direct action on the
contractile mechanism of striated muscle, the motor end plate,
or the nerve ﬁber. MET is metabolized by the liver and
excreted in the urine as unidentiﬁed metabolites. Hepatic
cytochrome P450 enzymes play a role in the metabolism of
MET [3].
Literature survey revealed that, RP-HPLC [4–8], LC–MS
[9], HPTLC [10] and UV spectrophotometric methods [11,12]
are available for the estimation of MET alone or in combina-
tion with diclofenac sodium. Among them two methods are
stability indicating methods, in which limited stress conditions
were applied. In the modern analytical laboratory, there is
always need for signiﬁcant stability-indicating methods (SIMs)
of analysis. Environmental factors, such as temperature, pH,
buffer species, ionic strength, light, oxygen, moisture, addi-
tives and excipients, can play an important role in the stability
of drug substances. Stress testing can help in identifying
degradation products and provide important information
about the intrinsic stability of drug substances [13]. With the
advent of the International Conference on Harmonization
(ICH) guidelines [14], requirements for the establishment of
SIMs have become more clearly mandated. Moreover, kinetic
studies and accelerated stability experiments are important to
solve problems encountered in quality control and to predict
the expiry dates of pharmaceutical products. The scientiﬁc
novelty of the present work is that the suggested method
represents the ﬁrst kinetics study of MET degradation using
HPLC. In addition, it is more efﬁcient and accurate than the
reported HPLC methods. Suitability of the proposed method
for determination of diclofenac potassium (which is found in
combination drug products) is also tested.2. Experimental
2.1. Chemicals and reagents
Pharmaceutical grade metaxalone was gifted by Dr. Reddy’s
Laboratories Ltd. (Hyderabad, India). Methanol and acetoni-
trile (HPLC grade) were purchased from Merck Chemical
Company (India). Potassium dihydrogen orthophosphate,
o-phosphoric acid, hydrochloric acid, sodium hydroxide and
30% hydrogen peroxide used were of analytical grade and
purchased from S D Fine Chem. Ltd. (Mumbai, India). Buffer
was prepared by dissolving 1360 mg (10 mM) of potassium
dihydrogen orthophosphate in 980 mL of HPLC grade water,
and 4 mL of triethylamine (0.4%) was added, pH was adjusted
to 3.0 with o-phosphoric acid and made up to 1 L with HPLC
grade water.
2.2. HPLC instrumentation and chromatographic conditions
The HPLC system consisted of two pumps (Analytical
Technologies P2230 HPLC pump), a manual injector with
20 mL capacity per injection, and a temperature-controlledcolumn oven. The UV–vis detector (Analytical Technologies
UV 2230) was operated at a wavelength of 225 nm. The
software used was chromatography workstation A-2000, ver-
sion 1.6. Columns used were Lichrospher C 18, 250 mm 4.6
mm, 5.0 mm (Merck, Germany), Atlantis C 18, 250 mm 4.6
mm, 5.0 mm (Waters Corporation, USA) and Dr. Maisch
C-18, 250 mm  4.6 mm, 5.0 mm (GMBH, Germany).
Chromatographic separation of MET was achieved at
temperature 2572 1C using a Dr. Maisch RP C18 (250 mm
4.6 mm, 5 mm) analytical column; the mobile phase consisted
of acetonitrile–potassium dihydrogen orthophosphate buffer
with 4 mL of triethyl amine (0.4%; pH 3.0; 10 mM; 58:42, v/v)
at a ﬂow rate of 1.0 mL/min. pH of buffer was adjusted with
o-phosphoric acid. Before use, the mobile phase was ﬁltered
through a 0.22 mm nylon membrane ﬁlter and sonicated for
15 min. Injection volume was 20 mL, and the optimum
wavelength selected for quantiﬁcation was 225 nm.
2.3. Construction of the calibration curve
Standard stock solution of MET was prepared in methanol at
a concentration of 10 mg/mL and further diluted with the
mobile phase to furnish working standard stock solution of
100 mg/mL. The working standard stock solution was diluted
with the mobile phase to prepare calibration samples in the
concentration range of 1–100 mg/mL. Triplicate injections of
20 mL were made for each calibration sample and chromato-
graphed under the speciﬁed HPLC conditions described
previously. Peak areas were plotted against the corresponding
concentration to obtain the calibration curve.
2.4. Forced degradation of MET
2.4.1. Hydrolytic conditions: acid, alkali and water induced
degradation
One milliliter of the standard stock solution was transferred to
each of three 10 mL volumetric ﬂasks and the volume was
made up to the mark with 5 M HCl, 0.01 M NaOH, and water
separately. These were kept at 60 1C on a thermostatic water
bath for 6 days.
2.4.2. Oxidizing conditions: hydrogen peroxide-induced
degradation
One milliliter of the standard stock solution was transferred to a
10 mL volumetric ﬂask and the volume was made up to the mark
with 10% H2O2. This was kept at room temperature for 6 days.
2.4.3. Thermal conditions: dry heat induced degradation
One milliliter of the standard stock solution was transferred to a
10 mL volumetric ﬂask and the volume was made up to the mark
with methanol. This was kept at 60 1C in an oven for 6 days.
2.5. Sample collection, storage and preparation
Before collecting samples, the volume was made up to the
mark with respective solvent. 200 mL of the sample was
collected at 0th, 1st, 2nd, 3rd, 4th, 5th and 6th day. The
samples from acid and base induced degradation were neu-
tralized by adding 200 mL of appropriate strength of NaOH
and HCl. All samples were stored at 2–8 1C in the refrigerator.
On the day of analysis samples were diluted with the mobile
Kinetics study of metaxalone degradation by HPLC 433phase up to 10 mL, ﬁltered with a 0.22 mm membrane syringe
ﬁlter and injected three times for each sample into HPLC.3. Results and discussion
3.1. HPLC method development and optimization
The UV absorption spectrum of MET shows absorption
maxima at 219 and 279 nm; the response at 219 nm was
higher than that of 279 nm, but detection wavelength of
225 nm was selected for chromatographic monitoring to
reduce the base-line noise at 219 nm and to get the better
response than from monitoring at 279 nm. For HPLC method
development initially the mobile phase used was acetonitrile
and water at different proportions, but the peak shape was not
good, so water was replaced by phosphate buffer. Different
molar concentrations of the phosphate buffers were prepared
in the range of 10–25 mM and tested; there was no difference
in the chromatographic behavior of MET in the tested range
and the tailing factor observed was 2.57. pH of the buffer was
also varied between 2.5 and 6.5 and peak shape was improved
at pH 3.0, so that it was selected. For further improvement of
peak shape, triethyl amine was tested at different concentra-
tion levels (0.1–0.5%) and it was found that 4 mL of 0.4% of
triethyl amine was optimum, which resulted in a tailing factor
of 1.62. Finally the optimized mobile phase composition for
MET was acetonitrile–potassium dihydrogen orthophosphate
buffer with 4 mL of triethyl amine (0.4%; pH 3.0; 10 mM;
58:42, v/v) at a ﬂow rate of 1.0 mL/min. A model chromato-
gram for the standard is shown in Fig. 2A.
3.2. Solution stability
The stability of MET in the mobile phase was investigated by
analyzing the standard of MET (20 mg/mL) at 0, 3, 6, 9, 12Figure 2 Representative chromatograms of MET standard (20 mg/
mL) [A] and stress samples under acidic (5 M HCl) [B], basic
(0.01 M NaOH) [C], neutral [D], oxidative (10% H2O2) [E] and
dry heat [F] conditions.and 24 h. No signiﬁcant variation in the peak area of standard
solution was observed (RSD¼1.52%) and also no additional
peaks were found in the chromatogram, indicating that the
MET was stable in the mobile phase.
3.3. Method validation
To conﬁrm the suitability of the method for its intended
purpose, the method was validated in accordance with ICH
guidelines [15], for system suitability, linearity, limit of detec-
tion (LOD), limit of quantiﬁcation (LOQ), accuracy, preci-
sion, speciﬁcity and robustness.
3.3.1. System suitability
System-suitability test was an integral part of method devel-
opment and has been used to ensure adequate performance of
the chromatographic system. Retention time (Rt), capacity
factor (k), number of theoretical plates (N) and tailing factor
(T) were evaluated for six replicate injections of the drug at a
concentration of 20 mg/mL. The results presented in Table 1
are within the acceptable limits.
3.3.2. Linearity
Linearity of the proposed method was evaluated according to
the ICH guidelines [15]. MET showed linearity in the con-
centration range of 1–100 mg/mL.The regression equation
obtained was Y¼30.43Xþ8.991, where Y is peak area and X
is concentration of MET (mg/mL). This equation was used to
determine the amount of MET present in the stress induced
samples.
3.3.3. Limits of detection and quantiﬁcation
The LOD was deﬁned as the lowest concentration of MET
resulting in a signal-to-noise ratio of 3:1 and LOQ was
expressed as a signal-to-noise ratio of 10:1. Due to the
difference in detector response, different concentrations ran-
ging from 0.01 to 2 mg/mL were prepared and analyzed. The
LOD and LOQ obtained were 0.3 and 1 mg/mL, respectively.
3.3.4. Accuracy
Accuracy of the method was determined by performing the
recovery experiments. Known amount of the standard at 80%,
100% and 120% levels was fortiﬁed to the degradation
sample. Peak area of the standard was calculated by the
difference of peak area between fortiﬁed and unfortiﬁed
samples. Three replicate samples of each concentration level
were prepared and the percentage recovery at each level (n¼3)
was determined (Table 2). For MET, the results obtained are
in good agreement with the added amounts.Table 1 System suitability data.
Property Mean7SD
(n¼6)
RSD
(%)
Required
limits
Retention time Rt 5.0570.01 0.20 RSDr2%
Capacity factor k 1.19070.004 0.33 –
Theoretical plates
N
285707240 0.84 N42000
Tailing factor T 1.6270.03 1.85 Tr2
Table 2 Recovery of the standard from the stress sample by standard addition method.
Level of standard
added (%)
Amount of
standard
added (mg)
Peak area (mean7SD) (n¼3) Amount of
standard
found (mg)Sample Standardþsample Standard RSD a(%)
80 40 44273 166778 122576 0.49 39.95
100 50 34975 188479 153574 0.28 50.14
120 60 24073 207574 183575 0.29 60.00
aRSD (%) of standard.
Table 3 Results for the analysis of intra-day and inter-
day precision.
Concentration
(mg/mL)
Intra-day
precision
Inter-day
precision
Peak
area a
RSD
(%)
Peak
area a
RSD
(%)
10 32472 0.65 32572 0.53
30 97876 0.64 97578 0.79
50 158379 0.57 1585711 0.71
80 2550712 0.49 2549713 0.50
aValues are expressed as mean7SD (n¼6).
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Intra-day and inter-day precision was evaluated by injecting
four different concentrations (10, 30, 50, and 80 mg/mL) of
MET. For intra-day variation, sets of six replicates of the four
concentrations were analyzed on the same day; for inter- day
variation, six replicates were analyzed on six different days.
The intra-day and inter-day precision (% RSD) was found to
be less than 2% (Table 3), indicating that the method was
precise.3.3.6. Speciﬁcity
Speciﬁcity is the ability to measure accurately and speciﬁcally the
analyte of interest in the presence of other components that may
be expected to be present in the sample matrix. The speciﬁcity of
the HPLC method is illustrated in Fig. 2, where complete
separation of MET was noticed in the presence of degradants.
The average Rt7standard deviation for MET was found to be
5.05 70.01 min, for six replicates. The peaks obtained were
sharp and had clear baseline separation. Speciﬁcity of the
method is further conﬁrmed by adding diclofenac potassium to
the MET solution and analyzed. There was no interference from
diclofenac potassium and it was eluted at 9.4 min. This indicates
that the developed method was speciﬁc and also applicable to
simultaneous estimation of diclofenac potassium and MET in
combination drug products.3.3.7. Robustness
A method is robust if it is unaffected by small changes in
operating conditions. To evaluate HPLC method robustness a
few parameters were deliberately varied. The parameters
included variation of C18 columns from different manufac-
turers, pH of the buffer, ﬂow rate and percentage of acetoni-
trile in the mobile phase. Two analytical columns were usedduring the experiment, one from Germany (Lichrospher C 18,
column) and the other from USA (Atlantis C 18 column).
Each of the three examined factors (pH, ﬂow rate, and
acetonitrile percentage) selected was changed one at a time
to estimate the effect. Replicate injections (n¼6) of standard
solution (20 mg/mL) were performed under small changes of
chromatographic parameters (factors). Flow rate was varied
by 170.1 mL/min; level of acetonitrile in the mobile phase
was varied by 5872% (v/v), while pH was varied by 3.070.1.
Results obtained are presented in Table 4, indicating that the
results remained unaffected by small variations of these
parameters. The results from the two columns indicated that
there is no signiﬁcant difference between the results from the
two columns.
3.4. Stability-indicating property
An analytical method is stability-indicating if this method can
separate all the process-related impurities and all the degrada-
tion products from the major peak of the sample. The 6th day
chromatograms for various stress induced samples are pre-
sented in Fig. 2 B–F. The acid degraded sample showed one
additional peak and at the end around 62% of drug was
degraded. Base degraded samples showed one major addi-
tional peak at Rt 2.90 min and around 85% of drug was
degraded at the end. For neutral hydrolysis, oxidative and dry
heat conditions, around 29%, 45% and 15% of MET was
degraded at the end respectively. Among the tested conditions
degradation was mild in neutral hydrolysis and thermal
conditions compared to other conditions. In all above cases
the degradant peaks did not interfere with the MET peak,
suggesting that the method enabled speciﬁc analysis of MET
in the presence of its degradation products.
3.5. Kinetic investigation
Treatment of MET under speciﬁed stress conditions resulted in a
gradual decomposition of MET in all conditions. Since the
degradation was performed with a large excess of solvent
(9 mL) compared to drug solution (1 mL), the degradation of
MET followed pseudo-ﬁrst-order kinetics [16] as a linear relation-
ship between log percentage of MET remaining and time was
established, having good correlation coefﬁcients (Fig. 3). Pseudo-
ﬁrst-order is the term used when two reactants are involved in the
reaction but one of them is in such a large excess that any change
in its concentration is negligible compared with the change in
concentration of the other reactant (drug). The kinetic parameters
are presented in Table 5. Rate constant (K), time left for 50%
potency (t1/2) and time left for 90% potency (t90) for each stress
Table 4 Results for the analysis of robustness.
Factors Level Retention time (min) Tailing factor Peak area
Flow rate (mL/min) 0.9 5.10 1.62 640
1 5.05 1.61 651
1.1 5.02 1.63 638
Mean7SD (n¼6) 5.0570.04 1.6270.02 643.0076.72
Percentage of acetonitrile in the mobile phase (v/v) 56 5.12 1.65 640
58 5.06 1.62 649
60 5.01 1.62 635
Mean7SD (n¼6) 5.0670.05 1.6370.02 641.0077.09
pH of the mobile phase 2.9 5.05 1.62 640
3.0 5.05 1.63 643
3.1 5.06 1.64 642
Mean7SD (n¼6) 5.0570.03 1.6370.02 642.0071.52
Columns from different manufacturers a 5.05 1.65 641
b 5.06 1.61 643
Mean7SD (n¼6) 5.0570.01 1.6370.03 642.0071.41
(a) Lichrospher: C18, 250 mm 4.6 mm, 5 mm.
(b) Atlantis: C18, 250 mm 4.6 mm, 5 mm.
R2 = 0.9822
R2 = 0.9807
R2 = 0.9728
R2 = 0.9914
R2 = 0.9962
0
0.5
1
1.5
2
2.5
0 1 2 3 4 5 6 7
2 
+ 
lo
g 
C t
/C
o
Time (Days)
5 M HCl
Neutral
Dry heat
10 % Hydrogen
peroxide
0.01 M NaOH
Figure 3 First order plots for the degradation of MET under
different stress conditions.
Table 5 Summary of MET degradation kinetics.
Stress
condition
K
(1/day)a
t1/2
(days)b
t90
(days)c
Degraded
(%)
5 M HCl 1.84 101 3.76 0.57 62.49
0.01 M NaOH 3.24 101 2.13 0.32 85.87
Neutral 4.37 102 15.85 2.40 29.20
10% H2O2 8.75 102 7.92 1.20 45.05
Dry heat 2.53 102 27.39 4.15 14.91
aRate constant per day.
bHalf-life.
cTime left for 90% potency.
Kinetics study of metaxalone degradation by HPLC 435condition were calculated using Eqs.(1), (2) and (3), respectively
[17]:
log Ct½  ¼
log½C0Kt
2:303
ð1Þ
t1=2 ¼
0:693
K
ð2Þ
t90 ¼
0:105
K
ð3Þ
where K is the rate constant, [C0] is the concentration of MET at
time t¼0 and [Ct] is its concentration at time t.
The K values per day were found to be 1.84 101, 3.24 10–1,
4.37 102, 8.75 102 and 2.53 102 for 5 M HCl, 0.01 MNaOH, neutral, 10% H2O2 and dry heat conditions respectively.
Extensive degradation was observed in basic conditions, where K
value was found to be the highest among all the tested conditions;
t1/2 and t90 values for all the tested stress conditions are shown in
Table 5, both t1/2 and t90 were found to be lowest (2.13 and 0.32
days) for basic condition (0.01 M NaOH) and highest (27.39 and
4.15 days) for dry heat condition.4. Conclusion
The proposed HPLC method was proved to be simple, accurate,
precise, speciﬁc and selective for quantitative analysis of MET in
the presence of its degradants and also suitable for simultaneous
estimation of MET and diclofenac in combination drug pro-
ducts. The degradation of MET was found to follow a pseudo-
ﬁrst-order reaction. The drug was extensively degraded under
basic stress conditions. The t1/2 values under different stress
conditions were found to decrease in the following order: dry
heat4neutral410% H2O245 M HCl40.01 M NaOH.
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